Skip to content

Evaluating a Preference-based Intervention for Increasing Colorectal Cancer Screening

Evaluating a Preference-based Intervention for Increasing CRC Screening

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00810771
Acronym
EPIIC
Enrollment
466
Registered
2008-12-18
Start date
2009-02-28
Completion date
2012-08-31
Last updated
2015-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Neoplasms

Keywords

Hospitals, Veterans, Mass Screening/utilization, Patient Preference, Prevention & Control, Epidemiology

Brief summary

The goal of this study is to evaluate whether an educational tool about colorectal cancer (CRC) completed on a computer that helps patients clarify their CRC screening preferences will lead to increased screening rates for CRC compared to standard information delivered via computer.

Detailed description

Background: Colorectal cancer (CRC) is a significant and preventable disease, yet CRC screening remains one of the lowest quality indicators in the VA healthcare system. Moreover, a recent VA directive recommends that CRC screening among Veterans should be based on their preferences, given that there is insufficient evidence to support recommending one test. However the impact of such a preference-based strategy on important outcomes, including screening adherence and cost, is unknown. Objectives: The broad hypothesis of the proposed study is that helping Veterans clarify their CRC screening preferences will lead to increased adherence. The framework conceptualizes that preference clarification leads to more informed decision-making and, eventually, to better adherence with screening. The specific aims are: 1) To test the effectiveness of a preference-tailored (PT) vs. standard information (SI) intervention for increasing Veterans' CRC screening adherence; 2) To assess the impact of the intervention on informed decision making, knowledge and attitudes toward screening, decisional outcomes, and intention to get screened; and 3) To conduct a cost effectiveness analysis of the PT intervention for increasing CRC screening across the VA. Methods: A randomized controlled trial of the PT vs. SI decision tool will be conducted in the Ann Arbor and Pittsburgh VA healthcare systems. The intervention was developed by the PI working with the Center for Health Communication Research at the University of Michigan. Eligible patients will be 552 (276 per group) Veterans between 50 and 78 who are due for CRC screening, and who have a primary care visit scheduled within the upcoming 4-6 weeks. Those at high risk (e.g., family or personal history of CRC) will be excluded. Providers will be informed of the study via regular mail and email. In Ann Arbor providers will be given the opportunity to opt-out their participants if they choose to do so. In Pittsburgh providers will be given lists of their participants as they are being considered for the study and will be given the chance to remove any potential participants from the contact list. Potential participants will be mailed an introductory letter. Those who do not opt-out will contacted by telephone. Participants will come to their primary care visit 40 minutes early, at which time they will complete informed consent. The intervention will be delivered via the Internet, and participants will be randomized to the PT or SI arm at the time of log-in. Study measures are consistent with the conceptual framework and based on the Preventive Health Model. Preference information will be collected through the computer program. Secondary outcomes and independent variables will be collected via telephone survey 3 days following the intervention. Adherence to screening will be collected from medical charts at 6 months. CRC screening information in a sub-sample of 80 Ann Arbor Veterans, not in either the PT or SI groups, will also be collected to measure usual care (UC). Pittsburgh will use the External Peer Review Program (EPRP) for the collection of clinical performance measures, more specifically CRC screening rates, to serve as an effective substitute for the UC group. Hypotheses related to each aim will be tested using multi-level modeling to control for between-provider effects. The overall hypothesis is that patients in the PT group will have higher rates of adherence to CRC screening at the 6 month follow-up point. Cost effectiveness analysis will determine whether a preference-based screening strategy could be cost effective for the VA healthcare system. The PI will work with the investigative team to disseminate the results through local and national VA websites, publications and presentations. Status: Active, not recruiting.

Interventions

A computer based educational overview of CRC and CRC test options will be presented to the subject. The subject will be given a handout with a brief description of each of the screening options and will include the test that they have chosen as their preferred test. The subjects will be asked to take this handout to their upcoming clinic appointment and to discuss the screening options with their care provider.

BEHAVIORALPreference-tailored Information

A preference elicitation exercise that will generate a list of the three top attributes for the subject and the CRC screening test most consistent with these attributes. Subjects will be provided with a handout to take to their clinic appointment as the Standard Information group does, but with the addition of a listing of their top attributes and the test most consistent with their top attributes.

Sponsors

US Department of Veterans Affairs
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE

Eligibility

Sex/Gender
ALL
Age
50 Years to 78 Years
Healthy volunteers
Yes

Inclusion criteria

* Clinic appointment at Ann Arbor or Pittsburgh VA during recruitment period. * Age 50-78. * Not up to date with CRC screening according to VA and USPSTF guidelines. * At average risk for CRC (no history of CRC, adenomatous colon polyps, inflammatory bowel disease, and no family history of CRC). * Has current address and telephone number listed in medical record.

Exclusion criteria

* DNR/DNI code status. * Metastatic cancer. * Stage D congestive heart failure. * Severe COPD. * Coronary artery disease (CAD) and MI within one year or CAD and unstable angina within 6 months. * Dementia. * Inability to conduct activities of daily living. * Life expectancy less than one year. * Other - anything else that limits CRC screening options. * Scheduled for a colonoscopy, sigmoidoscopy, DCBE, or CTC. * prior participation in this study * unable to contact after 2 introductory letters (at least 6 months apart)

Design outcomes

Primary

MeasureTime frameDescription
Colorectal Cancer (CRC) Screening Rate.Within 6 months of Decider Guider intervention.The CRC Screening rate reports percentage of participant adherence with any Colorectal Cancer Screening test within 6 months of Decider Guider intervention. Decider Guider is a tool to help patients make an informed choice about colon cancer testing.

Secondary

MeasureTime frameDescription
Colorectal Cancer Screening (CRCS) Knowledge and Attitudes.3-5 days after Decider Guider intervention.Outcome measure measuring knowledge of CRCS using 8-item knowledge measure (all true/false questions) developed for study, scaled and categorized into low/moderate/high knowledge, where low = low knowledge and high = high knowledge.
Decisional Satisfaction3-5 days after Decider Guider intervention.Outcome measures measuring decisional satisfaction using 7-item scale categorized into low, moderate, high. Decisional satisfaction is a measure that was first developed by Margaret Holmes Rover and colleagues (Med Decis Making. 1996 Jan-Mar;16(1):58-64) to assess the perspective of a patient involved in a medical decision with the decision making process. The measure includes questions related to overall satisfaction, and satisfaction with the amount of information received, involvement in, degree of consistency with values, and time to make the decision. The measure includes 5 questions each on a 5 point scale where higher scores = higher satisfaction. When scaled into one overall measure of decision satisfaction, lower scores = lower satisfaction and higher scores = higher satisfaction.
Number of Elements of Braddock's Informed Decision Making (IDM) Model Discussed With Provider3-5 days after Decider Guider interventionOutcome measure using 6 items measuring degree of participation in IDM. Scaled and recategorized into Low, Moderate and High level of IDM. The range is from 1 (low level of IDM) to 6 (high level of IDM).
Self Efficacy.3-5 days after Decider Guider intervention.Outcome measure measuring self-efficacy using 5-item measure, dichotomized into low vs. high self-efficacy (confidence) in getting screened.
If Colorectal Cancer Screening Screening (CRCS) Discussed With Provider.3-5 days after Decider Guider intervention.Outcome measure measuring percentage of participants discussing CRCS with provider using single question (yes/no): did you discuss Colorectal Cancer Screening with your provider?
Intent to Get Colorectal Cancer Screening.3-5 days after Decider Guider intervention.Outcome measure measuring intent to get CRC screening using 5-item stage of readiness scale. Intent is measured by looking at the highest 2 items (I think I will get screened and I am committed to getting screened).

Countries

United States

Participant flow

Recruitment details

The Usual Care group is not counted toward the Enrollment total. See description of group below for additional details.

Pre-assignment details

The Usual Care group is not counted toward the Enrollment total. See description of group below for additional details.

Participants by arm

ArmCount
Preference-tailored (PT) Intervention
Preference-tailored Information: A preference elicitation exercise generated a list of the three top attributes for the subject and the CRC screening test most consistent with these attributes. Subjects were provided with a handout to take to their clinic appointment as were the Standard Information group, but with the addition of a listing of their top attributes and the test most consistent with their top attributes.
198
Standard Information (SI) Intervention
Standard Information: A computer based educational overview of CRC and CRC test options was presented to the subject. The subject was given a handout with a brief description of each of the screening options and which included the test that they have chosen as their preferred test. The subjects were asked to take this handout to their upcoming clinic appointment and to discuss the screening options with their care provider.
197
Usual Care
Due to budget and time constraints this group is not powered as a true study arm but is being used to assess the impact of our baseline physician information letter and to control for any other interventions of system-wide initiatives that may have occurred during the study timeframe and impact rated of CRC screening.
84
Total479

Baseline characteristics

CharacteristicStandard Information (SI) InterventionUsual CarePreference-tailored (PT) InterventionTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
50 Participants16 Participants43 Participants109 Participants
Age, Categorical
Between 18 and 65 years
147 Participants68 Participants155 Participants370 Participants
Age, Continuous60.6 Years59.5 Years60.1 Years60.35 Years
Region of Enrollment
United States
197 participants84 participants198 participants479 participants
Sex: Female, Male
Female
11 Participants3 Participants4 Participants18 Participants
Sex: Female, Male
Male
186 Participants81 Participants194 Participants461 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
0 / 2320 / 2340 / 84
serious
Total, serious adverse events
3 / 2323 / 2340 / 84

Outcome results

Primary

Colorectal Cancer (CRC) Screening Rate.

The CRC Screening rate reports percentage of participant adherence with any Colorectal Cancer Screening test within 6 months of Decider Guider intervention. Decider Guider is a tool to help patients make an informed choice about colon cancer testing.

Time frame: Within 6 months of Decider Guider intervention.

ArmMeasureValue (NUMBER)
Preference-tailored (PT) InterventionColorectal Cancer (CRC) Screening Rate.40.1 percentage of participants
Standard Information (SI) InterventionColorectal Cancer (CRC) Screening Rate.40.2 percentage of participants
Usual CareColorectal Cancer (CRC) Screening Rate.19.3 percentage of participants
Secondary

Colorectal Cancer Screening (CRCS) Knowledge and Attitudes.

Outcome measure measuring knowledge of CRCS using 8-item knowledge measure (all true/false questions) developed for study, scaled and categorized into low/moderate/high knowledge, where low = low knowledge and high = high knowledge.

Time frame: 3-5 days after Decider Guider intervention.

Population: Data was not collected for Usual Care arm.

ArmMeasureGroupValue (NUMBER)
Preference-tailored (PT) InterventionColorectal Cancer Screening (CRCS) Knowledge and Attitudes.Low13.1 percentage of participants
Preference-tailored (PT) InterventionColorectal Cancer Screening (CRCS) Knowledge and Attitudes.Moderate66.2 percentage of participants
Preference-tailored (PT) InterventionColorectal Cancer Screening (CRCS) Knowledge and Attitudes.High20.7 percentage of participants
Standard Information (SI) InterventionColorectal Cancer Screening (CRCS) Knowledge and Attitudes.High17.4 percentage of participants
Standard Information (SI) InterventionColorectal Cancer Screening (CRCS) Knowledge and Attitudes.Low14.9 percentage of participants
Standard Information (SI) InterventionColorectal Cancer Screening (CRCS) Knowledge and Attitudes.Moderate67.7 percentage of participants
p-value: 0.671Chi-squared
Secondary

Decisional Satisfaction

Outcome measures measuring decisional satisfaction using 7-item scale categorized into low, moderate, high. Decisional satisfaction is a measure that was first developed by Margaret Holmes Rover and colleagues (Med Decis Making. 1996 Jan-Mar;16(1):58-64) to assess the perspective of a patient involved in a medical decision with the decision making process. The measure includes questions related to overall satisfaction, and satisfaction with the amount of information received, involvement in, degree of consistency with values, and time to make the decision. The measure includes 5 questions each on a 5 point scale where higher scores = higher satisfaction. When scaled into one overall measure of decision satisfaction, lower scores = lower satisfaction and higher scores = higher satisfaction.

Time frame: 3-5 days after Decider Guider intervention.

Population: Data was not collected for Usual Care arm.

ArmMeasureGroupValue (NUMBER)
Preference-tailored (PT) InterventionDecisional SatisfactionLow16.6 Percentage of participants
Preference-tailored (PT) InterventionDecisional SatisfactionModerate35.4 Percentage of participants
Preference-tailored (PT) InterventionDecisional SatisfactionHigh48 Percentage of participants
Standard Information (SI) InterventionDecisional SatisfactionLow29.4 Percentage of participants
Standard Information (SI) InterventionDecisional SatisfactionModerate22.8 Percentage of participants
Standard Information (SI) InterventionDecisional SatisfactionHigh47.7 Percentage of participants
p-value: 0.002Chi-squared
Secondary

If Colorectal Cancer Screening Screening (CRCS) Discussed With Provider.

Outcome measure measuring percentage of participants discussing CRCS with provider using single question (yes/no): did you discuss Colorectal Cancer Screening with your provider?

Time frame: 3-5 days after Decider Guider intervention.

Population: Data was not collected for Usual Care arm.

ArmMeasureValue (NUMBER)
Preference-tailored (PT) InterventionIf Colorectal Cancer Screening Screening (CRCS) Discussed With Provider.65.1 percentage of participants
Standard Information (SI) InterventionIf Colorectal Cancer Screening Screening (CRCS) Discussed With Provider.67.4 percentage of participants
p-value: 0.35Chi-squared
Secondary

Intent to Get Colorectal Cancer Screening.

Outcome measure measuring intent to get CRC screening using 5-item stage of readiness scale. Intent is measured by looking at the highest 2 items (I think I will get screened and I am committed to getting screened).

Time frame: 3-5 days after Decider Guider intervention.

Population: Data was not collected for Usual Care arm.

ArmMeasureValue (NUMBER)
Preference-tailored (PT) InterventionIntent to Get Colorectal Cancer Screening.76.8 percentage of participants
Standard Information (SI) InterventionIntent to Get Colorectal Cancer Screening.72.6 percentage of participants
p-value: 0.186Chi-squared
Secondary

Number of Elements of Braddock's Informed Decision Making (IDM) Model Discussed With Provider

Outcome measure using 6 items measuring degree of participation in IDM. Scaled and recategorized into Low, Moderate and High level of IDM. The range is from 1 (low level of IDM) to 6 (high level of IDM).

Time frame: 3-5 days after Decider Guider intervention

Population: Data was not collected for Usual Care arm.

ArmMeasureValue (MEAN)
Preference-tailored (PT) InterventionNumber of Elements of Braddock's Informed Decision Making (IDM) Model Discussed With Provider5.72 Degree of participation
Standard Information (SI) InterventionNumber of Elements of Braddock's Informed Decision Making (IDM) Model Discussed With Provider5.70 Degree of participation
p-value: 0.873Chi-squared
Secondary

Self Efficacy.

Outcome measure measuring self-efficacy using 5-item measure, dichotomized into low vs. high self-efficacy (confidence) in getting screened.

Time frame: 3-5 days after Decider Guider intervention.

Population: Data was not collected for Usual Care arm.

ArmMeasureGroupValue (NUMBER)
Preference-tailored (PT) InterventionSelf Efficacy.Low64.1 percentage of participants
Preference-tailored (PT) InterventionSelf Efficacy.High35.9 percentage of participants
Standard Information (SI) InterventionSelf Efficacy.Low61.4 percentage of participants
Standard Information (SI) InterventionSelf Efficacy.High38.6 percentage of participants
p-value: 0.576Chi-squared

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026